Peter Sidaway
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
- COVID-19 and healthcare impacts
- Physiology top 10%
- Adenosine and Purinergic Signaling
Papers in
- Oncology 79
- Cancer Immunotherapy and Biomarkers 34
- CAR-T cell therapy research 11
-
- Prostate Cancer Treatment and Research 18
- Lung Cancer Treatments and Mutations 14
- Renal cell carcinoma treatment 10
- Co-authors
- Julie Sanderson (3 shared papers)Nuwan Niyadurupola (2 shared papers)David C. Broadway (2 shared papers)Jeremy D. Rhodes (1 shared paper)Ning Ma (1 shared paper)Andrew Osborne (1 shared paper)Julie Ann Eldred (1 shared paper)Andrew J. O. Smith (1 shared paper)
- Journals
- Nature Reviews Clinical Oncology (194 papers)Nature Reviews Urology (55 papers)Nature Reviews Nephrology (11 papers)Nature Reviews Neurology (4 papers)PLoS ONE (2 papers)
- Partner nations
- United KingdomAustraliaJapan
In The Last Decade
Peter Sidaway
260 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 84
- Oncology 350
- Physiology 37
- Cancer Research 106
- Genetics 66
- Ophthalmology 54
Countries citing papers authored by Peter Sidaway
This map shows the geographic impact of Peter Sidaway's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Sidaway with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Sidaway more than expected).
Fields of papers citing papers by Peter Sidaway
This network shows the impact of papers produced by Peter Sidaway. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Sidaway. The network helps show where Peter Sidaway may publish in the future.
Co-authors
The 16 scholars most cited alongside Peter Sidaway, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 275 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 71 | |
| 2 | 2013 | 65 | |
| 3 | 2017 | 65 | |
| 4 | 2012 | 41 | |
| 5 | 2010 | 37 | |
| 6 | 2019 | 21 | |
| 7 | 2021 | 21 | |
| 8 | 2017 | 19 | |
| 9 | 2015 | 17 | |
| 10 | 2017 | 17 | |
| 11 | 2017 | 15 | |
| 12 | 2016 | 13 | |
| 13 | 2018 | 13 | |
| 14 | 2015 | 12 | |
| 15 | 2016 | 12 | |
| 16 | 2016 | 11 | |
| 17 | 2022 | 11 | |
| 18 | 2014 | 10 | |
| 19 | 2016 | 10 | |
| 20 | 2018 | 10 |
About Peter Sidaway
Peter Sidaway is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Urology and Genetics, having authored 275 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (34 papers), Bladder and Urothelial Cancer Treatments (20 papers), Prostate Cancer Treatment and Research (18 papers), Lung Cancer Treatments and Mutations (14 papers), Cancer Genomics and Diagnostics (14 papers), Urinary Bladder and Prostate Research (11 papers), CAR-T cell therapy research (11 papers) and Renal cell carcinoma treatment (10 papers). The work is most often cited by research in Oncology (350 citations), Physiology (37 citations), Cancer Research (106 citations), Genetics (66 citations) and Ophthalmology (54 citations). Peter Sidaway has collaborated with scholars based in United Kingdom, Australia and Japan. Frequent co-authors include Julie Sanderson, Nuwan Niyadurupola, David C. Broadway, Jeremy D. Rhodes, Ning Ma, Andrew Osborne, Julie Ann Eldred, Andrew J. O. Smith, John R. Reddan and Ian Michael Wormstone. Their work appears in journals such as Nature Reviews Clinical Oncology, Nature Reviews Urology, Nature Reviews Nephrology, Nature Reviews Neurology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.